Contrary to indoor allergen exposure (e.g. house dust mite), there is no reliable quantitative association between pollen exposure and symptoms of allergic diseases. Therefore we studied localization and release of major allergens from timothy grass (Phleum pratense L.) pollen using different methods and pollen grain sources. Localization of major allergens Phl p 5 and Phl p 1 was visualized by field emission scanning electron microscopy after anhydrous fixation and immunogold silver staining in a three–dimensional reconstruction; Phl p 5 was found in the cytoplasm and on the exine, Phl p 1 in the intine. No allergens were found inside the starch granules. Allergen liberation from pollen grains was studied in vitro under physiological conditions (30 min, 37°C) at pH 6.0, 7.4 and 9.0. Besides total protein measurements in the supernatant, major allergens were determined by immunoblot, Phl p 5 was quantitated by ELISA. There were striking differences in total protein and major allergen release between freshly collected and commercially available grass pollen grains as well as among freshly collected pollen between rural meadows and areas near high–traffic roads. There was a significantly different release of total protein being lowest in supernatants from commercially available pollen grains (rural/traffic vs. commercial, p<0.001), and of Phl p 5 major allergen (rural>traffic>commercial, p<0.005). Therefore, allergen bioavailability seems to be an important parameter in order to establish reliable dose–response relationships for the outdoor allergen response. Pollen grains incubated in aqueous protein–free buffer solution were also found to secrete significant amounts of eicosanoids namely prostaglandin E2 and leukotriene B4. Pollen grains thus do not act only as allergen carriers but also might have important implications on early events as initiators of allergy.

1.
Wüthrich B: Epidemiology of the allergic diseases: Are they really on the increase? Int Arch Allergy Appl Immunol 1989;90:3–10.
2.
Behrendt H, Krämer U, Dolgner R, Hinrichs J, Willer H, Hagenbeck H, Schlipköter HW: Elevated levels of total serum IgE in East German children: Atopy, parasites, or pollutants? Allergo J 1993;2:31–40.
3.
Ring J, Behrendt H, Vieluf D: New Trends in Allergy IV together with Environmental Allergy Allergotoxicology III. Berlin, Springer, 1997.
4.
Wichmann H: Environment, life–style and allergy: The German answer. Allergo J 1995;6: 315–316.
5.
Behrendt H, Friedrichs KH, Krämer U, Hitzfeld B, Becker WM, Ring J: The role of indoor and outdoor air pollution in allergic diseases. Prog Allergy Clin Immunol 1995;3: 83–89.
6.
Brunekreef B, Janssen NAH, de Hartog J, Marssema H, Knape M, van Vliet P: Air pollution from truck traffic and lung function in children living near motorways. Epidemiology 1997;8:298–303.
7.
Miyamoto T, Takafuji S: Environment and Allergy; in Ring J, Przybilla B (eds): New Trends in Allergy III. Berlin, Springer, 1991, pp 459– 468.
8.
Rusnak C: The impact of pollution on allergic disease. Allergy 1994;49:21–27.
9.
Weiland SK, Mundt KA, Rückmann A, Keil U: Self–reported wheezing and allergic rhinitis in children and traffic density on street of residence. Ann Epidemiol 1994;4:243–247.
10.
Fahlbusch B, Schlenvoigt G, Müller W–D, Weber B, Jäger L: A two–site monoclonal antibody ELISA for the quantification of group V allergens in grass extracts. Clin Exp Allergy 1994;24:752–757.
11.
Schäppi GF, Monn C, Wüthrich B, Wanner HU: Direct determination of allergens in ambient aeorosols: Methodological aspects. Int Arch Allergy Immunol 1996;110:364–370.
12.
Hausen B, Vieluf I: Allergiepflanzen – Pflanzenallergene. Munich, Ecomed Verlag, 1997.
13.
Behrendt H, Becker WM, Friedrich KH, Darsow U, Tomingas R: Interaction between aeoroallergens and airborne particulate matter. Int Arch Allergy Immunol 1992;99:425–428.
14.
Behrendt H, Becker WM, Fritzsche C, Sliwa–Tomczok W, Tomczok J, Friedrichs KH, Ring J: Air pollution and allergy: Experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 1997;113:69–74.
15.
Friedrichs KH, Behrendt H: Preliminary results of ambient measurements with a multistage impactor. Arch Environ Contam Toxicol 1993;25:405–410.
16.
Spieksma F, Kramps JA, van der Linden AC, Nikkels BH, Plomp A, Koerten HK, Dijkman JH: Evidence of grass pollen allergenic activity in the smaller micronic atmospheric fraction. Clin Exp Allergy 1990;20:273–280.
17.
Behrendt H, Friedrichs K, Kainka–Staenicke E, Darsow U, Becker WM, Tomingas R: Allergens and pollutants in the air – A complex interaction; in Ring J, Przybilla B (eds): New Trends in Allergy III. Berlin, Springer, 1991, pp 467–478.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.